Trending News
News

News
FDA Approves First Supplemental Test for Chagas Disease
The U.S. Food and Drug Administration have approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to T. cruzi, which causes Chagas disease, a serious and potentially fatal parasitic infection.

News
Kamada Launches New Website for its Human Ultrapure Transferrin
Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, has announced the launching of a new e-commerce website for its Human Ultrapure Transferrin.

News
Geron to Focus on its Novel Cancer Programs
Geron Corporation has announced that they will be focusing on first-in-class oncology programs. As a consequence, the Company will discontinue further development of its stem cell programs and is seeking partners for these novel assets.

News
InteRNA Technologies Announces Establishment of Supervisory Board
InteRNA Technologies B.V., a drug discovery and development company engaged in the development of microRNA-based therapeutics for oncology, has announced the establishment of its Supervisory Board.

News
NHS Urged to Prepare for ‘Genetic Revolution’
The ability to bring biologists into the data analysis phase will be key to achieving this important goal.

News
Chimps’ Lab Days Numbered
Advocacy groups pushing to end research in U.S.

News
Retina Implant AG Gains Approval To Expand Clinical Trial Across Europe
Majority of Patients Report Restoration of Useful Vision in Daily Life

News
Strategic Alliances to Host Special Sessions at SLAS2012
Three industry partners to discuss global scientific trends.

News
Monoolein Lipid Phases as Incorporation and Enrichment Materials for Membrane Protein Crystallization
In this study researchers have shown that the formation of the lipidic phases and the incorporation of the membrane protein into such materials can be separated experimentally.

News
Key Patents Issued to Celerus Diagnostics
Company Secures Long-term Control of Rapid IHC® Technologies
Advertisement